Trimodal Therapy: Combining Hyperthermia with Repurposed Bexarotene and Ultrasound for Treating Liver Cancer

Abstract

Repurposing of existing cancer drugs to overcome their physical limitations, such as insolubility, represents an attractive strategy to achieve enhanced therapeutic efficacy and broaden the range of clinical applications. Such an approach also promises to offer substantial cost savings in drug development efforts. Here we use repurposed FDA-approved topical agent bexarotene (Targretin™), currently in limited use for cutaneous manifestations of T-cell lymphomas, and re-engineer it for use in solid tumor applications by forming self-assembling nanobubbles. Physicochemical characterization studies of the novel prodrug nanobubbles demonstrated their stability, enhanced target cell-internalization capability and highly controlled release profile in response to application of focused ultrasound energy. Using an in vitro model of hepatocellular carcinoma and an in vivo large animal model of liver ablation, we demonstrate the effectiveness of bexarotene prodrug nanobubbles when used in conjunction with catheter-based ultrasound, thereby highlighting the therapeutic promise of this trimodal approach.

Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells

“…5 A-D). The results obtained from 3-(4′,5′-dimethylthiazol-2′-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (49) suggested that 5 was effective in Cur-regulated cell growth inhibition of all used cancer cell lines. Moreover, the growth inhibition efficiency was significantly improved in these cells, as supported by the decrease of IC 50 values to a biostatistically significant level of P < 0.0001 (SI Appendix, Table S1).…”

DFT study of the therapeutic potential of phosphorene as a new drug-delivery system to treat cancer

“…Typical therapeutic treatments still experience impeded target specicity, poor bioavailability and organ toxicity. 1,2 To improve the pharmacological properties and bioavailability of many drugs, drug-delivery systems are introduced to release a controlled amount of drug at the intended target sites. 3 In the eld of medicine, nanotechnology has played a revolutionary role in which nanostructures are used to deliver drugs to specic disease-centred cells.…”

Defined Host–Guest Chemistry on Nanocarbon for Sustained Inhibition of Cancer

“…[53] Briefly, ≈80% confluent MCF-7 cells were treated for 72 h with Nic formulations. At the end of the incubation period, cells were washed, spun and collected in 400 μL of lysis buffer.…”